Effects of intraperitoneal administration of IFN-α for one, four, and fourteen days on amino acid levels in various rat brain regions

Journal of Interferon and Cytokine Research

Volumn 25, Issue 4, 2005, Pages 187-191

  Yokoyama, Masamoto ^a   Suzuki, Eiji ^a   Sato, Taku ^a   Maruta, Shuji ^a   Inada, Ken ^a   Watanabe, Shigeru ^a   Miyaoka, Hitoshi ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; ARGININE; GLUTAMIC ACID; GLYCINE; RECOMBINANT ALPHA INTERFERON; TAURINE;

AMINO ACID METABOLISM; ANIMAL MODEL; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; DEPRESSION; MALE; MENTAL DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

AMINO ACIDS; ANIMALS; BRAIN; BRAIN CHEMISTRY; INJECTIONS, INTRAPERITONEAL; INTERFERON-ALPHA; MALE; RATS; RATS, WISTAR;

EID: 17144385817     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.187     Document Type: Article

References (28)

1. DIEPERINK, E., WILLENBRING, M., and HO, S.B. (2000). Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am. J. Psychiatry 157, 867-876.
2. RENAULT, P.F., HOOFNAGLE, J.H., PARK, Y., MULLEN, K.D., PETERS, M., JONES, B., RUSTGI, V., and JONES, A. (1987). Psychiatric complications of long-term interferon alfa therapy. Arch. Intern. Med. 147, 1577-1580.
3. STOKES, P.E., and SILES, C.R. (1988). The hypothalamic-pituitary- adrenocortical axis in major depression. Endocrinol. Metab. Clin. North Am. 17, 1-19.
4. LICINO, J., KING, M., and HAUSER, P. (1998). Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes. Semin. Oncol. 25, 30-38.
5. MILLER, A. (1998). Neuroendocrine and immune system interactions in stress and depression. Psychiatr. Clin. North Am. 21, 443-463.
6. ZOON, K.C., and ARNHEITER, H. (1984). Studies of the interferon receptors. Pharmacol. Ther. 24, 259-278.
7. FERIS, E.D. (1954). Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N. Engl. J. Med. 251, 1006-1008.
8. BUNNEY, W.E., Jr., and DAVIS, J.M. (1965). Norepinephrine in depressive reaction. A review. Arch. Gen. Psychiatry 13, 483-494.
9. SCHILDKRAUT, J.J. (1965). The catecholamine hypothesis of affective disorders. Am. J. Psychiatry 122, 509-522.
10. KAMATA, M. (1999). Clinical and experimental studies on the effects of IFN on the central nervous system. Part II: Neurochemical effects of intracerebroventricular injection of IFN on monoamine concentration in the rat brain. Akita J. Med. 26, 61-68. (Japanese with English abstract.)
11. OKADA, F. (1995). Interferon-induced depression: just one of Bonhoeffer's exogene Reaktionstypen or a clue to understanding psychoimmunological aspects of depression? J. Mol. Med. 73, 99-100.
12. SMILEY, J.F., and GOLDMAN-RAKIC, P.S. (1996). Serotonegic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy. J. Comp. Neurol. 367, 431-443.
13. GERNER, R.H., and HARE, T.A. (1981). CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. Am. J. Psychiatry 138, 1098-1101.
14. GOLD, B.I., BOWERS, M.B., Jr., ROTH, R.H., and SWEENEY, D.W. (1980). GABA levels in CSF of patients with psychiatric disorders. Am. J. Psychiatry 137, 362-364.
15. SANACORA, G., MASON, G.F., ROTHMAN, D.L., BEHAR, K.L., HYDER, F., PETROFF, O.A., BERMAN, R.M., CHARNEY, D.S.. and KRYSTAL, J.H. (1999). Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 56, 1043-1047.
16. JANICKI, P.K. (1992). Binding of human alpha-interferon in the brain tissue membranes of rat. Res. Commun. Chem. Pathol. Pharmacol. 75, 117-122.
17. SAPHIER, D., WELCH, J.E., and CHULUYAN, H.E. (1993). α-Interferon inhibits adrenocortical secretion via μ1-opioid receptors in the rat. Eur. J. Pharmacol. 236, 183-191.
18. SAPHIER, D., ROERIG, S.C., ITO, C., VLASAK, W.R., FARRAR, G.E., BROYLES, J.E., and WELCH, J.E. (1994). Inhibition of neural and neuroendocrine activity by α-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat. Brain Behav. Immun. 8, 37-56.
19. DONZANTI, B.A., and YAMAMOTO, B.K. (1988). An improved and rapid HPLC-EC method for the isocratic separation of amino acid neurotransmitters from brain tissue and microdialysis perfusates. Life Sci. 43, 913-922.
20. SANACORA, G., MASON, G.F., ROTHMAN, D.L., and KRYSTAL, J.H. (2002). Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am. J. Psychiatry 159, 663-665.
21. SANACORA, G., MASON, G.F., ROTHMAN, D.L., HYDER, F., CIARCIA, J.J., OSTROFF, R.B., BERMAN, R.M., and KRYSTAL, J.H. (2003). Increased cortical GABA concentrations in depressed patients receiving ECT. Am. J. Psychiatry 160, 577-579.
22. BELOZERTSEVA, I.V., and ANDREEV, B.V. (1997). A pharmaco-ethological study of the GABA-ergic mechanisms regulating the depression-like behavior of mice. Zh. Vyssh. Nerv. Deiat. Im. I. P. Pavlova. 47, 1024-1031. (Russian with English abstract.)
23. BLALOCK, J.E., and SMITH, E.M. (1980). Human leukocyte interferon: structural and biological relatedness to adrenocortocotropic hormone and endorphins. Proc. Natl. Acad. Sci. USA 77, 5972-5974.
24. CORSMITT, E.P.M., HEIJLIGENBERG, R., ENDERT, E., ACKERMANS, M.T., SAUERWEIN, H.P., and ROMIJIN, J.A. (1996). Endocrine and metabolic effects of interferon-alpha in humans. J. Clin. Endocrinol. Metab. 81, 3265-3269.
25. DEL OLMO, N., GALARRETA, M., BUSTAMANTE, J., MARTIN DEL RIO, R., and SOLIS, J.M. (2000). Taurine-induced synaptic potentiation: role of calcium and interaction with LTP. Neuropharmacology 39, 40-54.
26. GALARRETA, M., BUSTAMANTE, J., MARTIN DEL RIO, R., and SOLIS, J.M. (1996). Taurine induces a long-lasting increase of synaptic efficacy and axon excitability in the hippocampus. J. Neurosci. 16, 92-102.
27. MENDOZA-FERNANDEZ, V., ANDREW, R.D., and BARAJAS-LOPEZ, C. (2000). Interferon-alpha inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus. Brain Res. 885, 14-24.
28. NAKAKI, T., MISHIMA, A., FUJII, T., SUZUKI, E., and SHITANI, F. (1997). Nitric oxide and neurodegenerative diseases. Curr. Top. Pulm. Pharmacol. Toxicol. 3, 157-163.